Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Carlo Incerti"'
Autor:
Gareth Baynam, Carlo Incerti, Daria Julkowska, Hanns Lochmüller, Christine M. Cutillo, Ruxandra Draghia-Akli, Christopher P. Austin, Petra Kaufmann, Sharon F. Terry, Anneliene H. Jonker, Lu Wang, Lilian P.L. Lau, Béatrice de Montleau, Kym M. Boycott, Domenica Taruscio, David Thomson, Diego Ardigò, Makoto Suematsu, Hugh Dawkins, Virginie Hivert, Irene Norstedt, Ana Rath
Publikováno v:
Clinical and Translational Science. 11:21-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ace0837dfafafd77b799eb75aac2f95
https://doi.org/10.1111/cts.12500
https://doi.org/10.1111/cts.12500
Publikováno v:
Clinical and Translational Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::1ace0837dfafafd77b799eb75aac2f95
Publikováno v:
The Quality Assurance Journal. 8:102-109
The European Union (EU) ‘Clinical Trials’ directive will be implemented in all EU member states in May 2004 and will have a significant impact on clinical research in the EU. Its advent has caused a stir amongst commercial companies and academics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e3c328af79bdc982bdde926a5fab036
https://doi.org/10.1002/qaj.271
https://doi.org/10.1002/qaj.271
Publikováno v:
The Journal of Clinical Pharmacology. 41:199-205
Sevelamer hydrochloride (Renagel) is a nonabsorbed phosphate-binding polymer approved for the treatment of hyperphosphatemia in adult hemodialysis patients. The authors studied the potential effect of sevelamer on the pharmacokinetics of two antihype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3e2e6257b9c9b69432d183fda348ca
https://doi.org/10.1177/00912700122009881
https://doi.org/10.1177/00912700122009881
Autor:
Roch Doliveux, Salahdine Chibout, Andrzej Rys, Pedro Ortun Silvan, Rudolf Strohmeier, Carlo Incerti, Richard Bergström, Ruxandra Draghia-Akli, Theodius Lennon, Peter Hongaard Andersen
Publikováno v:
Nature Biotechnology. 29:689-690
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::845af44afa813966d7c55c4aa9feef92
https://doi.org/10.1038/nbt.1944
https://doi.org/10.1038/nbt.1944
Publikováno v:
Journal of clinical pharmacology. 41(2)
Sevelamer hydrochloride (Renagel) is a nonabsorbed phosphate-binding polymer marketed for the treatment of hyperphosphatemia in adult patients receiving hemodialysis. Sevelamer also exhibits bile acid-binding properties resulting in LDL cholesterol l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7a20be71e54048976488dad057246b
https://pubmed.ncbi.nlm.nih.gov/11210401
https://pubmed.ncbi.nlm.nih.gov/11210401
Autor:
Rudolf Strohmeier, Richard Bergström, Pedro Ortun Silvan, Ruxandra Draghia-Akli, Peter Hongaard Andersen, Roch Doliveux, Andrzej Rys, Salahdine Chibout, Carlo Incerti, Theodius Lennon
Publikováno v:
Nature Biotechnology. 29:690-690
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ee19053b07b654a1e18b50f3ffdb224
https://doi.org/10.1038/nbt.1951
https://doi.org/10.1038/nbt.1951
Autor:
Carlo Incerti
Publikováno v:
Nature Reviews Drug Discovery. 6:106-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::238dc3a76a028751badab5fc0306f73f
https://doi.org/10.1038/nrd2250
https://doi.org/10.1038/nrd2250
Autor:
Emmanuelle Voisin, Sarah Garner, Thomas Lönngren, Moncef Slaoui, Yann Le Cam, Marc Dunoyer, David Uguen, Carlo Incerti
Publikováno v:
Orphanet Journal of Rare Diseases
There is growing recognition that the current research-and-development (R&D) and innovation-regulation ecosystem could be made more efficient to stimulate and support access to innovative therapies for those patients with rare, life-threatening disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2057c00e631e4452cbf6dcbe18b54ba6